Taking Stock After Gene Patents Are Invalidated
Wednesday, March 31, 2010 - 00:14
in Mathematics & Economics
Many biotechnology stocks fell as investors struggled to understand the impact of a ruling that threw out parts of two gene patents and called into question thousands more.